Article Information
History
- April 19, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Anneke Steens, PhD1,
- Mirjam J. Knol, PhD1,
- Wieke Freudenburg-de Graaf, MD2,3,
- Hester E. de Melker, PhD1,
- Arie van der Ende, PhD2,3,4 and
- Nina M. van Sorge, PhD2,3,4,*
- 1Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
- 2Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands
- 3Netherlands Reference Laboratory for Bacterial Meningitis, Amsterdam UMC, location AMC, Amsterdam, The Netherlands
- 4Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands
- ↵*Corresponding author:
Prof. dr. N.M. van Sorge, Amsterdam UMC location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Netherlands Reference Laboratory for Bacterial Meningitis, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. E-mail: N.M.vanSorge{at}amsterdamumc.nl; Phone: +31-(0)20-5664862
Posted April 19, 2022.
Pathogen- and type-specific changes in invasive bacterial disease epidemiology during the first year of the COVID-19 pandemic in the Netherlands
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos